CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 789489-789580
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T30145","span":{"begin":0,"end":91},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The primary outcome was the safety of Eculizumab in this group concurrently receiving IVIg."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T313","span":{"begin":0,"end":91},"obj":"Sentence"}],"text":"The primary outcome was the safety of Eculizumab in this group concurrently receiving IVIg."}